Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Elan Faces Double Threat To Blockbuster Drug Tysabri
WSJ
Thursday, June 17, 2010 - 11:32am
tags:
Elan, MS, Tysabri, Biogen Idec, Novartis, Gilenia
Arginetix, Immune Control Inc. merge to form Corridor Pharmaceuticals Read more: Arginetix, Immune Control Inc. merge to form Corridor Pharmaceuticals - Baltimore Business Journal
bizjournals.com
Thursday, June 17, 2010 - 11:29am
tags:
Arginetix, Immune Control Inc, Corridor Pharmaceuticals
Innophos Holdings, Inc. Declares Quarterly Dividend
American Chronicle
Thursday, June 17, 2010 - 11:27am
tags:
Innophos
India ready to invest in Russia's pharma sector
Economic Times, India
Thursday, June 17, 2010 - 11:24am
tags:
India
GlaxoSmithKline, Amfar Form Pact To Optimize HIV Treatment In Asia
WSJ
Thursday, June 17, 2010 - 11:22am
tags:
GSK, Amfar, HIV, Asia
Biotech Bargains
Investopedia
Thursday, June 17, 2010 - 11:17am
tags:
biotech, investors
Firstcall recommends `Buy` on Sun Pharma
MyIris, India
Thursday, June 17, 2010 - 11:13am
tags:
Sun Pharma, investors
US breakthrough for Phytopharm
BusinessWeekly, UK
Thursday, June 17, 2010 - 11:11am
tags:
Phytopharm, Cogane, Parkinson's Disease
Does The Canadian System Really Lower Prices?
Pharmalot
Thursday, June 17, 2010 - 11:08am
tags:
Canada
Novo Nordisk Moving Above Resistance
Traders Huddle
Thursday, June 17, 2010 - 11:07am
tags:
Novo Nordisk
Pfizer Establishes Rare-Disease Research Unit
PharmTech
Thursday, June 17, 2010 - 11:02am
tags:
Pfizer, R&D
Kun Run Biotechnology Announces That They Have Obtained the Manufacturing Approval for Entecavir from the China State Food and Drug Administration
PR NewsWire
Thursday, June 17, 2010 - 10:15am
tags:
Kun Run Biotechnology, Entecavir, hepatitis B
Takeda, CanBas: Ended Joint Study On Cancer Drug
Nikkei,com, Japan
Thursday, June 17, 2010 - 10:12am
tags:
Takeda, CanBas, lung cancer
Medicare cuts increase cancer treatments, study finds
Bioscience Technology
Thursday, June 17, 2010 - 10:09am
tags:
oncology
AstraZeneca loses Canadian court case over generic Nexium
PharmaTimes
Thursday, June 17, 2010 - 10:06am
tags:
AstraZeneca, Nexium, generics
Sun Pharma Gets US FDA Approval For Generic Keppra Injection
RTT News
Thursday, June 17, 2010 - 10:04am
tags:
Sun Pharma, Keppra, generics
Trius Gets SPA From FDA For Torezolid Phosphate Phase 3 Study
Pharmaceutical Business Review
Thursday, June 17, 2010 - 9:53am
tags:
Trius Therapeutics, Torezolid, skin infection
GSK gets conditional marketing nod in EU for pazopanib to treat RCC
Pharmabiz
Thursday, June 17, 2010 - 9:50am
tags:
GSK, Votrient, renal cell carcinoma
Hospira Announces Further Extension of Tender Offer for Shares of Javelin Pharmaceuticals
PR NewsWire
Thursday, June 17, 2010 - 9:47am
tags:
Hospira, Javelin
A.M. Vitals: Using Cheaper Genentech Eye Drug Could Save $500 Million a Year
WSJ
Thursday, June 17, 2010 - 9:46am
tags:
Avastin, Genentech, Lucentis, macular degeneration

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.